TSC1
TSC1 (hamartin) forms the TSC1-TSC2 tumor suppressor complex that acts as a GTPase-activating protein for Rheb, keeping mTORC1 inactive under low-nutrient conditions. Loss-of-function mutations cause tuberous sclerosis complex, characterized by benign tumors in multiple organs.
Key Takeaways
- •TSC1 (Hamartin) and TSC2 (Tuberin) form the master "brake" on mTORC1 signaling.
- •TSC1 stabilizes TSC2; without it, the brake fails, and cell growth proceeds unchecked.
- •Insulin and inflammation inhibit this complex, while energy stress (AMPK) activates it.
- •Loss of TSC1 leads to Tuberous Sclerosis Complex, a disease of benign tumors.
Basic Information
- Gene Symbol
- TSC1
- Full Name
- Tuberous Sclerosis Complex 1
- Also Known As
- Hamartin
- Location
- 9q34.13
- Protein Type
- Scaffold protein
- Protein Family
- TSC Complex (with TSC2)
Related Isoforms
Key SNPs
Associated with age of diagnosis in estrogen receptor-positive breast cancer.
Linked to pulmonary function measures (FEV1/FVC) in general populations.
Associated with susceptibility to pulmonary traits and lung function.
Associated with altered gene expression in eQTL studies.
Overview
TSC1 (Hamartin) is the essential partner of TSC2 (Tuberin). Together, they form the "TSC Complex," which serves as the primary negative regulator—or "brake"—for the mTORC1 growth pathway.
While TSC2 contains the catalytic machinery that physically turns off the activator Rheb, TSC1 is the stabilizer that keeps the complex together. Without TSC1, TSC2 is rapidly degraded by the cell's waste disposal systems (ubiquitin-proteasome). Therefore, a loss of TSC1 is functionally equivalent to a loss of TSC2: the brake is removed, and mTORC1 enters a state of constitutive hyperactivity, leading to uncontrolled cell growth and benign tumors.
Conceptual Model
A simplified mental model for the pathway:
If you break the chain (TSC1 mutation), the anchor (TSC2) is lost to the bottom of the sea, and the ship drifts uncontrollably (Tumors).
Core Health Impacts
- • Tumor prevention: Prevents tumor formation by limiting cell size and proliferation.
- • Immune integration: Integrates immune signals (inflammation) to modulate growth.
- • Stem cell protection: Protects stem cells from exhaustion by maintaining quiescence.
- • Brain development: Essential for proper brain development and cortical layering.
Protein Domains
Coiled-Coil Domain
The structural "grip" that binds to TSC2. Mutations here disrupt the interaction, destabilizing the entire complex.
Rho-GTPase Domain
TSC1 activates Rho to regulate the actin cytoskeleton, affecting cell migration (relevant in metastasis).
Phosphorylation Sites
Specific residues (e.g., Ser487) targeted by inflammatory kinases (IKK) to turn off TSC1 during immune responses.
Upstream Regulators
AMPK Activator
The energy sensor. Phosphorylates TSC2 (stabilized by TSC1) to boost its "brake" function, shutting down mTOR when ATP is low.
GSK3β Activator
Glycogen Synthase Kinase 3 beta. Phosphorylates TSC2 to enhance its activity, often in cooperation with AMPK.
REDD1 Activator
Induced by hypoxia (low oxygen). It sequesters 14-3-3 proteins, freeing the TSC complex to inhibit mTOR.
Genotoxic Stress Activator
DNA damage (via p53) activates the TSC complex to pause the cell cycle and prevent replication of damaged errors.
Downstream Targets
Rheb Inhibits
The direct target. The TSC complex acts as a GAP (GTPase Activating Protein) for Rheb, converting it from Active (GTP) to Inactive (GDP).
mTORC1 Inhibits
Indirect target. By inactivating Rheb, TSC1/2 cuts off the essential activator for the mTOR kinase.
Autophagy Activates
By inhibiting mTORC1, the TSC complex releases the brake on ULK1, allowing autophagy to proceed.
S6K / 4E-BP1 Inhibits
Downstream effectors of mTORC1 that are silenced when TSC1 is active.
Role in Aging
The TSC complex is the central integration hub for longevity signals. By keeping mTORC1 low, it mimics the effects of caloric restriction. Enhanced TSC1 activity protects against age-related diseases by ensuring cellular quality control (autophagy).
Insulin Sensitivity
The TSC complex prevents the negative feedback loop from mTORC1 to IRS1. When TSC is active, cells remain sensitive to insulin.
Stem Cell Maintenance
By inhibiting mTOR, TSC1 prevents stem cells from dividing unnecessarily, preserving the regenerative pool for old age.
Immune Function
TSC1 regulates the balance between immune activation and suppression. Loss of TSC1 in immune cells can lead to autoimmunity.
Disorders & Diseases
Tuberous Sclerosis Complex (TSC)
Genetic disorder caused by mutations in TSC1 or TSC2. Characterized by hamartomas (benign tumors) in the brain, kidneys, heart, and skin, and often epilepsy.
Lymphangioleiomyomatosis (LAM)
A rare lung disease affecting women, caused by somatic mutations in TSC genes. Smooth muscle-like cells grow uncontrollably, destroying lung tissue.
Epilepsy
Disruption of the TSC complex in developing neurons leads to disorganized brain structure (dysplasia), a common cause of intractable childhood epilepsy.
Cancer
While germline mutations cause benign tumors, somatic loss of TSC1 is seen in bladder, kidney, and breast cancers, driving malignant progression.
Interventions
Supplements
Activates AMPK, which strengthens the TSC brake on mTOR.
Similar to metformin; activates AMPK to enhance TSC2 phosphorylation.
May inhibit mTORC1 partially by disrupting the upstream Akt signal that inhibits TSC2.
Supports AMPK activity, indirectly reinforcing TSC complex function.
Lifestyle
Lowers insulin (which inhibits TSC) and raises AMPK (which activates TSC), doubly enforcing the "brake".
Depletes growth factors and energy, ensuring the TSC complex remains active and mTOR remains off.
Acutely activates AMPK, turning on the TSC brake in muscle to prioritize energy production over growth.
Medicines
The "backup brake." It inhibits mTORC1 directly, compensating for a failed or overwhelmed TSC complex.
A rapamycin analog (rapalog) used to treat TSC-associated tumors (SEGA, angiomyolipoma).
Often used off-label or in trials to support metabolic health via the AMPK-TSC axis.
Lab Tests & Biomarkers
Genetic Testing
Definitive diagnosis for Tuberous Sclerosis. Identifies pathogenic germline variants.
Imaging
Detects cortical tubers and subependymal giant cell astrocytomas (SEGAs).
Screens for angiomyolipomas (kidney tumors) common in TSC.
Hormonal Interactions
Insulin Inhibitor
Activates Akt, which phosphorylates TSC2. This forces the complex to detach from the lysosome (Brake OFF).
IGF-1 Inhibitor
Works identically to insulin via the PI3K-Akt pathway to suppress TSC1/2 activity.
TNF-α Inhibitor
Inflammatory cytokine. Signals via IKKβ to phosphorylate TSC1 directly, suppressing the complex (Inflammation -> Growth).
Wnt Inhibitor
Wnt signaling inhibits GSK3β, thereby reducing the activation of the TSC complex.
Deep Dive
Network Diagrams
The Rheb GAP Cycle
Signal Integration Map
Mechanism: The Molecular Brake
The TSC complex functions as a GTPase Activating Protein (GAP) toward Rheb. This is a technical term for a simple concept: Rheb has an “On” switch (GTP) and an “Off” switch (GDP).
Normally, Rheb wants to hold onto GTP and stay “On,” activating mTOR. The TSC complex forces Rheb to burn that fuel (hydrolyze GTP), converting it to the “Off” state (GDP). As long as TSC1/2 is active, Rheb is kept dormant, and mTOR cannot fire.
The Decision Hub
The TSC complex is the cell’s computer. It takes multiple inputs—Energy (AMPK), Growth Factors (Akt), Inflammation (IKK), and Oxygen (REDD1)—and calculates a single output: “Grow” or “Wait”.
Remarkably, different inputs hit different parts of the machine. Insulin hits TSC2 to release the brake. Inflammation hits TSC1 to do the same. Energy stress hits TSC2 to clamp the brake down harder. This multi-port design allows for nuanced control of metabolism.
Relevant Research Papers
Links go to PubMed (abstracts are public); some papers also offer free full text via PMC or the publisher.
The landmark paper identifying the chromosomal location of the TSC1 gene.
Established that TSC1 (Hamartin) and TSC2 (Tuberin) bind together to form a functional complex.
Crucial mechanistic paper linking the TSC tumor suppressors directly to the inhibition of mTOR.
Revealed how inflammation (IKKbeta) turns off TSC1, explaining the link between obesity/inflammation and mTOR activation.
Identified the small GTPase Rheb as the missing link between the TSC complex and mTOR.
Demonstrated that TSC1's primary job is to prevent the rapid degradation of TSC2.